Article Listing - Merck & Co to bank $175 million on selling its share of consumer JV with Johnson & Johnson

PER SCHEME ADMITS NEW MEMBERS

20 April 1992

A request for participation in the Switzerland-based Scheme for the Mutual Recognition of Evaluation Reports on Pharmaceutical Products (PER Scheme)...

FRENCH HEALTH COST CONTROL DEAL

20 April 1992

A revamped agreement between the French government and the medical profession on health care cost control (Marketletter March 16) has...

QUIDEL AND BECTON DICKINSON DEAL

20 April 1992

Quidel Corp has announced that it has signed a cross licensing agreement covering proprietary technology with Becton Dickinson. Under separate...

BULLETIN REViEWS EPOETIN

20 April 1992

Addressing the role of recombinant erythropoietin as a treatment for anemic patients with renal failure and other potentially responsive conditions,...

AIDS AND THE COMMUNITY

20 April 1992

World AIDS Day 1992, Decem-ber 1, will focus on the pivotal role to be played by communities in taking up...

US BIOSCIENCE STOCK SALE CANCELLED

20 April 1992

Marion Merrell Dow, the US pharmaceutical company, has withdrawn its request for registration and sale of all the common stock...

TEVA'S GENERIC BRONCHODILATOR

20 April 1992

Israel's Teva Pharmaceutical Industries' US subsidiary, the Lemmon Company, has received approval from the US Food and Drug Administration to...

POSSIBLE ARTHRITIS TREATMENT DISCOVERED

20 April 1992

Biochemists at the University of Toronto, Canada, have discovered an antioxidant compound, purpurogallin, which they say could prevent cell damage...

DAIICHI'S SP-PG

20 April 1992

Japan's Daiichi Pharmaceu-tical reports that it plans to establish a medical research group in the USA to test the putative...

IMMUNOSTIMULANT ACTION FOR CEFTAZIDIME?

20 April 1992

Scientists at a research institute of the Azerbaijan Health Ministry in the former USSR reportedly have discovered an immunostimulant action...

Showing 94431-94440 of 95573 articles